CXCL13 Levels Indicate Treatment Responsiveness to Fingolimod in MS Patients. Karaaslan Z, Kurtuncu M, Akcay HI, Gunduz T, et al. Eur Neurol 2022;85:69-71.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Karaaslan Z, Kurtuncu M, Akcay HI, Gunduz T, et al. CXCL13 Levels Indicate Treatment Responsiveness to Fingolimod in MS Patients. Eur Neurol 2022;85:69-71.
PMID: 34340233